BOSTON SCIENTIFIC CORP (BSX) Net Cash Provided by (Used in) Financing Activities USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Boston Scientific Corp quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2024.
  • Boston Scientific Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $1.57B.
Net Cash Provided by (Used in) Financing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Financing Activities, Quarterly Data (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $1.57B +$1.64B Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 $5M $5M +$553M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
Q1 2023 -$69M -$63M -1050% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 -$548M -$548M -$453M -477% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
Q1 2022 -$6M +$89M +93.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$95M -$95M -$388M -132% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
Q1 2021 -$95M -$351M -137% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $293M $293M -$2.68B -90.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q1 2020 $256M -$1.87B -88% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $2.97B $2.97B +$1.54B +108% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q1 2019 $2.13B +$2B +1536% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $1.43B $1.43B +$1.32B +1202% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-23
Q1 2018 $130M +$145M Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 $110M $110M +$316M Jan 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q1 2017 -$15M +$36M +70.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-01
Q4 2016 -$206M -$206M -$1.48B -116% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-19
Q1 2016 -$51M +$43M +45.7% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 $1.28B $1.28B +$1.43B Jan 1, 2015 Dec 31, 2015 10-K 2018-02-20
Q1 2015 -$94M +$66M +41.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-04
Q4 2014 -$150M -$150M +$474M +76% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-23
Q1 2014 -$160M -$46M -40.4% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q4 2013 -$624M -$624M +$140M +18.3% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-24
Q1 2013 -$114M +$18M +13.6% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q4 2012 -$764M -$764M +$964M +55.8% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-25
Q1 2012 -$132M +$359M +73.1% Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-05-07
Q4 2011 -$1.73B -$1.73B -$1.22B -240% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-26
Q1 2011 -$491M -$505M -3607% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-03
Q4 2010 -$508M -$508M Jan 1, 2010 Dec 31, 2010 8-K 2013-05-29
Q1 2010 $14M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.